Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo

International Journal of Oncology

Volumn 41, Issue 1, 2012, Pages 169-178

  Li, Huibing ^a,b   Chen, Lingchao ^c   Zhang, Anling ^a,b   Wang, Guangxiu ^a,b   Han, Lei ^a,b   Yu, Kai ^a,b   Pu, Peiyu ^a,b   Kang, Chunsheng ^a,b   Huang, Qiang ^a,b  

^a Tianjin Neurological Institute   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; IKK ; Invasion; Proliferation

Indexed keywords

BETA TUBULIN; CYCLIN D1; CYCLINE; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; I KAPPA B ALPHA; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR GROWTH;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; I-KAPPA B KINASE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR BURDEN;

EID: 84862893179     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1452     Document Type: Article

References (40)

1. James CD and Olson JJ: Molecular genetics and molecular biology advances in brain tumors. Curr Opin Oncol 8: 188-195, 1996. (Pubitemid 26200552)
2. Westermark B and Nister M: Molecular genetics of human glioma. Curr Opin Oncol 7: 220-225, 1995.
3. Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-229, 2002.
4. Surawicz TS, Davis F, Freels S, Laws EJ and Menck HR: Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40: 151-160, 1998. (Pubitemid 29010168)
5. Shimada H, Ambros IM, Dehner LP, et al: The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86: 364-372, 1999. (Pubitemid 29327594)
6. Peters RT, Liao SM and Maniatis T: IKK is part of a novel PMA-inducible I (kappa) B kinase complex. Mol Cell 5: 513-522, 2000.
7. Sweeney SE, Hammaker D, Boyle DL and Firestein GS: Regulation of c-Jun phosphorylation by the IκB kinase-ε complex in fibroblast-like synoviocytes. J Immunol 174: 6424-6430, 2005. (Pubitemid 40663836)
8. Eddy SF, Guo S, Demicco EG, et al: Inducible IκB kinase/IκB kinase ε expression is induced by CK2 and promotes aberrant nuclear factor-κB activation in breast cancer cells. Cancer Res 65: 11375-11383, 2005. (Pubitemid 41823949)
9. Adli M and Baldwin AS: IKK-i/IKKε controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 281: 26976-26984, 2006. (Pubitemid 44401726)
10. Boehm JS, Zhao JJ, Yao J, Kim SY and Firestein R: Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129: 1065-1079, 2007. (Pubitemid 46891036)
11. Guo JP, Shu SK, He L, et al: Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol 175: 324-333, 2009.
12. Péant B, Diallo JS, Dufour F, et al: Over-expression of IκB-kinase-ε(IKKε/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate 69: 706-718, 2009.
13. Gebäck T, Schulz MMP, Koumoutsakos P and Detmar M: Short technical reports. Biotechniques 46: 265-274, 2009.
14. Guan H, Zhang H, Cai J, et al: IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kappaB. J Pathol 223: 436-445, 2011.
15. Chen F: Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. Cancer Res 64: 8135-8138, 2004.
16. Harris J, Oliere S, Sharma S, et al: Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J Immunol 177: 2527-2535, 2006. (Pubitemid 44202170)
17. Sethi G, Sung B and Aggarwal BB: Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233: 21-31, 2008.
18. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB and Berens ME: Molecular targets of glioma invasion. Cell Mol Life Sci 64: 458-478, 2007.
19. Stupp R, Hegi ME, Mason WP, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009.
20. Qin B and Cheng K: Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res 12: R74, 2010.
21. Pearson G, English JM, White MA and Cobb MH: ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J Biol Chem 276: 7927-7931, 2001.
22. MacKeigan JP, Murphy LO and Blenis J: Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591-600, 2005. (Pubitemid 40796982)
23. Hsu SY, Kaipia A, McGee E, Lomeli M and Hsueh AJ: Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci USA 94: 12401-12406, 1997. (Pubitemid 27492540)
24. Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100, 2002. (Pubitemid 37328796)
25. Zagzag D, Friedlander DR, Margolis B, et al: Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 33: 49-55, 2000.
26. Sung B, Pandey MK, Nakajima Y, et al: Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol Cancer Ther 7: 191-201, 2008.
27. Lee TK, Poon RT, Wo JY, et al: Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res 67: 8800-8809, 2007. (Pubitemid 47437456)
28. Luo JL, Tan W, Ricono JM, et al: Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694, 2007. (Pubitemid 46606879)
29. Gilmore TD, Koedood M, Piffat KA and White DW: Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 13: 1367-1378, 1996.
30. Lee CH, Jeon YT, Kim SH and Song YS: NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29: 19-35, 2007. (Pubitemid 46985299)
31. Naugler WE and Karin M: NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26, 2008.
32. Mattioli I, Geng H and Sebald A, et al: Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J Biol Chem 281: 6175-6183, 2006. (Pubitemid 43847547)
33. Yang YC, Huang WF and Chuan LM, et al: In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells. Chemotherapy 54: 438-446, 2008.
34. De Oliveira MG, Lauxen IS, Chaves AC, Rados PV and Sant'Ana FM: Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions. Med Oral Patol Oral Cir Bucal 13: E275-E280, 2008.
35. Yamamoto H, Ochiya T, Takeshita F, et al: Enhanced skin carcino-genesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation. Cancer Res 62: 1641-1647, 2002. (Pubitemid 34408483)
36. Trent J, Meltzer P, Rosenblum M, et al: Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83: 470-473, 1986. (Pubitemid 16080035)
37. Kondraganti S, Mohanam S, Chintala SK, et al: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 60: 6851-6855, 2000. (Pubitemid 32059151)
38. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006. (Pubitemid 43723979)
39. Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A and Mackay AR: Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ 10: 353-367, 1999. (Pubitemid 29242601)
40. Han YP, Tuan TL, Wu H, Hughes M and Garner WL: TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114: 131-139, 2001. (Pubitemid 32118063)